Mack N. Barnes - Concepedia

Author

Mack N. Barnes

Also Known As

M BARNES, M Barnes, M N Barnes, M. Barnes, M. N. Barnes, M. N. Barnes Iii, M.N. Barnes, MACK N. BARNES, Mack Barnes, Mack N Barnes

107

Publications

4.5K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Gynecologic Oncology Group University of Helsinki Helsinki University Hospital Roswell Park Comprehensive Cancer Center

About

Mack N. Barnes is an author at University of Alabama at Birmingham specializing in medicine, ovarian cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	2.2K
2	Public Health	5	5	158
3	Health Sciences	2	2	62
4	Engineering	1	1	48
5	Management	1	1	48

Mack N. Barnes

Publications

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study Carol Aghajanian, Michael W. Sill, Kathleen M. Darcy, Journal of Clinical Oncology	2011	312
Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells. Anna Kanerva, Galina Mikheeva, Victor Krasnykh, PubMed Synthetic VirologyImmunologyGene Delivery EfficiencySerotype 3Cancer Biology	2002	254
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncology group study David H. Moore, Shamshad Ali, Wui-Jin Koh, Gynecologic Oncology Vulvar DiseasesPhase Ii TrialRadiation TherapyMedicineGynecology	2011	231
Gene Transfer to Ovarian Cancer Versus Normal Tissues with Fiber-Modified Adenoviruses Anna Kanerva, Minghui Wang, Gerd Bauerschmitz, Molecular Therapy	2002	185
A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial. Ronald D. Alvarez, Mack N. Barnes, Jesús Gómez-Navarro, PubMed Gene TherapiesGene Transfer/expressionMedicineImmunologyHuman Ovarian Cancer	2000	161
Treatment of ovarian cancer with a tropism modified oncolytic adenovirus. Gerd Bauerschmitz, John Lam, Anna Kanerva, PubMed Endocrine-related CancerAd5-delta 24RgdMedicinePathologyGynecology	2002	157
An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene Expression Akseli Hemminki, Kurt R. Zinn, Bin Liu, Molecular Therapy	2001	127
The use of bevacizumab to palliate symptomatic ascites in patients with refractory ovarian carcinoma T. Michael Numnum, Rodney P. Rocconi, Jenny M. Whitworth, Gynecologic Oncology Symptomatic AscitesOncologyRefractory Ovarian CarcinomaCancer ManagementPathology	2006	125
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study Angeles Alvarez Secord, John A. Blessing, Deborah K. Armstrong, Gynecologic Oncology Phase Ii TrialMedicineMetronomic TherapyGynecologyCancer Treatment	2008	123
Adenoviral-Mediated Suicide Gene Therapy for Ovarian Cancer Ronald D. Alvarez, Jesús Gómez-Navarro, Minghui Wang, Molecular Therapy	2000	120

Page 1